Virtu Financial’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Virtu Financial’s Portfolio BIOR Stock Details BIOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,101	Closed	-$12K	–	2108
2024 Q1	$12K	Sell	1,101 -875	-44%	-$9.47K	﹤0.01%	1238
2023 Q4	$27K	Buy	+1,976	New	+$32K	﹤0.01%	1278
2023 Q2	–	Sell	-1,064	Closed	-$29K	–	2424
2023 Q1	$29K	Buy	+1,064	New	+$36.1K	﹤0.01%	1175
2022 Q4	–	Sell	-41	Closed	-$5K	–	2471
2022 Q3	$5K	Buy	+41	New	+$7.38K	﹤0.01%	1588
2022 Q2	–	Sell	-1,486	Closed	-$431K	–	2322
2022 Q1	$431K	Buy	+1,486	New	+$564K	0.03%	443
2021 Q1	–	Sell	-71	Closed	-$94K	–	2227
2020 Q4	$94K	Buy	+71	New	+$104K	0.01%	1075

Other funds holding BIOR

ACM

Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Virtu Financial's BIOR Position: Q2 2024 in Review

Virtu Financial sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q2 2024, closing a stake of 1,101 shares — an estimated $12K sold.

Virtu Financial first reported a position in BIOR in Q4 2020 and held it in 6 quarters. The position peaked at $431K in Q1 2022. 26 funds tracked by Wall St. Rank hold BIOR as of Q2 2024.

Virtu Financial reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Virtu Financial sold 1,101 Biora Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $12K.
Virtu Financial first reported a position in Biora Therapeutics, Inc. Common Stock in Q4 2020 and held it in 6 quarters.
Virtu Financial's Biora Therapeutics, Inc. Common Stock position peaked at $431K in Q1 2022.
26 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Virtu Financial's 13F filing for Q2 2024, filed 9 Aug 2024.